The asia pacific biobanking market size surpassed USD 16.66 billion in 2025 and is predicted to reach around USD 43.21 billion by 2035, registering a CAGR of 10% from 2026 to 2035.The market is influenced by rapid progress in genomic research, increasing cases of chronic diseases like cancer and diabetes, and significant funding from both government and private sectors in healthcare infrastructure.

Asia Pacific Biobanking Market Statical Scope

The Asia Pacific biobanking market is essential due to its fast growth in supporting personalized medicine, chronic disease research, and genomic projects in countries such as China, Japan, and India. It plays a key role in managing biospecimens like blood, tissue, and DNA for advanced drug discovery and vaccine development. The rising rates of cancer, diabetes, and cardiovascular diseases in the area necessitate biobanks for biomarker discovery and research into targeted therapies.

Strong government support and private sector funding, particularly in China and Japan, enhance advanced automated cold storage systems, which improve sample traceability and integrity. As pharmaceutical research and development shift to this region, biobanks offer crucial infrastructure for storing samples for both international and local clinical trials.

Asia Pacific Biobanking Market Share, By Sample Storage, 2025 (%)

• Blood - With a 60% share, the blood segment is the dominant part of the Asia Pacific biobanking market. Blood products, such as whole blood, plasma, and serum, are the most frequently stored and used biological samples for high-demand research in genomics, diagnostics, and immunology.
• Cells & Tissues - Holding a 30% share, the Cells & Tissues segment plays a vital role in the Asia Pacific biobanking market. It supports the region's growing emphasis on precision medicine, regenerative medicine, and advanced cancer research. As the fastest-growing biobanking market, APAC is heavily investing in the storage of high-quality stem cells and diseased tissues for personalized therapies and drug discovery.

Asia Pacific Biobanking Market Share, By Application, 2025 (%)

• Regenerative Medicines - Leading with a 45% share, the regenerative medicines segment is essential to the Asia Pacific biobanking market. It drives the high demand for storing stem cells, cord blood, and tissue samples necessary for advanced therapies. The rapid growth in R&D for cell and gene therapies, an aging population, and significant regional investment in chronic disease treatment make it a key growth driver.
• Life Science - With a 40% share, the Life Science segment is the foundation of the Asia Pacific biobanking market. It connects a wide range of biological samples with high-growth areas like drug discovery, personalized medicine, and genomics research. The APAC biobanking market is expected to grow rapidly, mainly due to increased investment in R&D.

Asia Pacific Biobanking Market Share, By Settings, 2025 (%)

• Academic Medical Institutions - With a 55% share, the Academic Medical Institutions segment is dominating the Asia Pacific biobanking market, serving as a key driver of innovation, sample collection, and high-quality research. As the region moves towards precision medicine, these institutions play a crucial role in providing well-annotated samples and connecting clinical research with therapeutic application.
• Pharmaceutical & Biotechnological Companies - Holding a 45% share, the Pharmaceutical & Biotechnological Companies segment is important to the Asia Pacific biobanking market as it drives the demand for high-quality biospecimens, specialized storage, and advanced laboratory services, especially in precision medicine and next-generation drug discovery.

Top Companies in the Asia Pacific Biobanking Market

• Thermo Fisher Scientific Inc.
• Tecan Trading AG
• QIAGEN
• Hamilton Company
• Brooks Life Sciences
• TTP Labtech
• VWR International, LLC.
• Promega Corporation
• Worthington Industries
• BD
• Merck KGaA
• Biokryo GmbH
• Cell&Co BioServices
• RUCDR Infinite Biologics
• Modul-Bio

Segments Covered in the Report

By Sample Storage

• Blood
• Cells & Tissues
• Others

By Application

• Regenerative Medicines
• Life Science
• Others

By Settings

• Academic Medical Institutions
• Pharmaceutical & Biotechnological Companies